Parthenogenetic embryonic stem cells with H19 siRNA-mediated knockdown as a potential resource for cell therapy

Author：            

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.29, Iss.2, 2012-01, pp. : 257-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential application of embryonic stem cells in Parkinson’s disease: drug screening and cell therapy

By Ho Hsin-Yi   Li Meng  

Regenerative Medicine, Vol. 1, Iss. 2, 2006-03 ,pp. : 175-182

Future Medicine

Access to resources Recommend Favorite

Developmental incompatibility of human parthenogenetic embryonic stem cells in mouse blastocysts

By Du Lili  

In Vitro Cellular & Developmental Biology - Animal, Vol. 48, Iss. 3, 2012-03 ,pp. : 156-164

Springer Publishing Company

Access to resources Recommend Favorite

siRNA Mediated Knockdown of Tissue Factor Expression in Pigs for Xenotransplantation

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1407-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stem Cells and Cell Therapy

By  

Cardiology, Vol. 117, Iss. 3, 2010-12 ,pp. : 198-198

Karger

Access to resources Recommend Favorite

Potential for pharmacological manipulation of human embryonic stem cells

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 169, Iss. 2, 2013-05 ,pp. : 269-289

John Wiley & Sons Inc

Access to resources Recommend Favorite